Get the tools used by (smart)2 investors.
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Degree of Operating Leverage (DOL) for Novartis AG ADR

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

NVS: Novartis AG ADR

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

112.14 USD
Price
– USD
Fair Value
–
Upside
96.06 - 120.92
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG ADR's Degree of Operating Leverage (DOL):

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.005.0010.0015.00
Performance Summary
  • Novartis AG ADR's latest twelve months degree of operating leverage (dol) is 2.68
  • Novartis AG ADR's degree of operating leverage (dol) for fiscal years ending December 2020 to 2024 averaged 5.09.
  • Novartis AG ADR's operated at median degree of operating leverage (dol) of 4.68 from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Novartis AG ADR's degree of operating leverage (dol) peaked in December 2022 at 13.68.
  • Novartis AG ADR's degree of operating leverage (dol) hit its 5-year low in December 2021 of -0.67.
  • Novartis AG ADR's degree of operating leverage (dol) decreased in 2021 (-0.67, -114.4%), 2023 (5.06, -63.0%), and 2024 (2.68, -47.0%) and increased in 2020 (4.68, +1,340.9%) and 2022 (13.68, -2,133.5%).

How does Novartis ADR's Degree of Operating Leverage (DOL) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Novartis AG ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Novartis ADR Degree of Operating Leverage (DOL) Benchmarks
NameTickerDegree of Operating Leverage (DOL)
Sandoz Group AGSWX:SDZ-4.47
Johnson & JohnsonBRSE:000943981-0.86
Teva Pharmaceutical Industries LimitedSWX:TEVA1.37
HealthcareSECTOR:HLTH.CH1.57
Eli Lilly and CoSWX:LLY1.95
Novartis AG ADRNYSE:NVS2.68
Roche Holding AGSWX:RO3.20
Viatris IncWBAG:VTRS3.95
Pfizer IncDB:PFE4.45
Bristol-Myers Squibb CompanyBRSE:BMY7.20
Merck & Co., Inc.BRSE:0106830539.81
Bayer AktiengesellschaftSWX:BAYN13.93

Metric Usage: Degree of Operating Leverage (DOL)

Hide this widget
degree_of_operating_leverage
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Degree of Operating Leverage (DOL) in the risk category include:

  • Cash Flow / Total Debt - A ratio used in two ways - a) to measure cash flow coverage and b) the inverse ratio to estimate the length of time needed to pay off debts.
  • Beta (1 Year) - A ratio that measures the risk or volatility of a company's share price in comparison to the market as a whole. Beta (1 Year) is calculated using one year of weekly returns.
  • Total Debt / Total Assets - A ratio that measures a company's total debt as a percentage of total assets.
  • Sloan Ratio - A formula developed by Richard Sloan in 1996 that measures the degree of accruals versus reported earnings.
View Full List

Search for metric or datapoint

Degree of Operating Leverage (DOL)

The degree of operating leverage measures the sensitivity of a company's operating income with respect to a change in revenue.

Definition of Degree of Operating Leverage (DOL)

Hide this widget
The degree of operating leverage measures the sensitivity of a company's operating income with respect to a change in revenue.

Sector Benchmark Analysis

All rights reserved. Terms Of Use